Andel Raises $4.5M to Revolutionize Pharmacy Benefits for Employers

Andel, a healthcare startup, has raised $4.5 million to launch a pioneering platform that allows employers to offer GLP-1 weight-loss medications at a reduced cost. This move addresses the fact that two-thirds of employers do not cover GLP-1 medications for weight loss, leaving employees struggling with increasing healthcare costs.

Andel's cooperative model empowers members to purchase medications directly from manufacturers at lower prices, which employers can further subsidize to make the drugs more affordable for their employees. The company aims to bridge the gap in healthcare access and provide a seamless experience for obtaining prescription medications. With the support from investors like Lightbank, Seedcamp, Bertelsmann Healthcare Investments, and others, Andel is set to redefine the U.S. pharmacy benefits model.

The startup's founders, Jay Bregman and Ritu Malhotra, bring extensive experience and expertise from their respective backgrounds, and their vision has garnered support from various stakeholders, including investors and industry experts. Andel's innovative approach is expected to launch nationwide in 2026, offering a transformative solution to the challenges in the healthcare and pharmacy benefits sector.

Source: PR NewsWire